These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20855786)

  • 21. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
    Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
    Anticancer Res; 2014 Dec; 34(12):7379-82. PubMed ID: 25503176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palifermin and chemotherapy-induced oral mucositis.
    Awada A; Genot MT; Klastersky J
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15788506
    [No Abstract]   [Full Text] [Related]  

  • 23. Palifermin and chemotherapy-induced oral mucositis.
    Palmieri C; Vigushin D
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15791703
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
    Dörr W; Bässler S; Reichel S; Spekl K
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Palifermin in the preventive treatment of oral mucositis in autograft patients: data on efficacy and tolerance following marketing approval].
    Onteniente S; Coullet V; Chemelle M; Lafont I; Pernot C; Guignard MH
    Therapie; 2008; 63(1):37-42. PubMed ID: 18387274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palifermin and chemotherapy-induced oral mucositis.
    Köstler WJ; Hejna M; Zielinski CC
    N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15791702
    [No Abstract]   [Full Text] [Related]  

  • 27. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
    Radtke ML; Kolesar JM
    J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia.
    Lucchese A; Matarese G; Ghislanzoni LH; Gastaldi G; Manuelli M; Gherlone E
    Leuk Lymphoma; 2016; 57(4):820-7. PubMed ID: 26428409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM; Lenz KL
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acanthosis nigricans in a patient treated with palifermin.
    Lee M; Grassi M
    Cutis; 2010 Sep; 86(3):136-7. PubMed ID: 21049730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of palifermin in the prevention of oral mucositis in patients with haematological cancers].
    Ayago Flores D; Ferriols Lisart R
    Farm Hosp; 2010; 34(4):163-9. PubMed ID: 20580585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
    Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
    J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palifermin dose should be adjusted to different therapy regimens.
    Verhagen MP; Wondergem MJ; Visser O
    Bone Marrow Transplant; 2009 Apr; 43(8):665. PubMed ID: 19029966
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.
    Wymenga AN; van der Graaf WT; Hofstra LS; Spijkervet FK; Timens W; Timmer-Bosscha H; Sluiter WJ; van Buuren AH; Mulder NH; de Vries EG
    Clin Cancer Res; 1999 Jun; 5(6):1363-8. PubMed ID: 10389920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palifermin: anaphylaxis, oedema and hyperpigmentation. Sucking ice is safer for preventing oral mucositis.
    Prescrire Int; 2009 Dec; 18(104):257. PubMed ID: 20050200
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial.
    Karthaus M; Rosenthal C; Huebner G; Paul H; Elser C; Hertenstein B; Krauter J; Scharmann T; Geissler RG; Heil G; Ganser A
    Bone Marrow Transplant; 1998 Oct; 22(8):781-5. PubMed ID: 9827976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
    Zalcberg JR; Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Cesano A; Gayko U; Chen MG; Clarke S
    J Clin Oncol; 2008 Mar; 26(8):1386-7. PubMed ID: 18323563
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation.
    Weigelt C; Haas R; Kobbe G
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):505-15. PubMed ID: 21417820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
    Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
    Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ice ball cryotherapy for chemotherapy-induced mucositis].
    Ohyama W; Kano Y; Akutsu M; Tsunoda S
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2675-7. PubMed ID: 7979433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.